|
|
|
|
|
by hamburglar1
1653 days ago
|
|
Is there a comprehensive white-paper anywhere with sample sizes and error bars? Otherwise this seems like an anecdote. "The sera were collected from subjects 3 weeks after receiving the second dose or one month after receiving the third dose of the Pfizer-BioNTech COVID-19 vaccine" How do we know this study isn't just measuring the effect of that additional week?
Also how many subjects was this sera pulled from? Are the subjects materially similar between the second and third dose groups? Not exactly surprising the people selling the third dose conclude that it is needed. It's like when the waiter recommends the most expensive option. |
|
A booster is the normal way to handle it. If there were a way to avoid it, at least one of the many companies working on this would have created it. And one for the regular flu, too, while they are at it, which has not happened in decades.